Combined anti-SARS-CoV-2 IgA, IgG, and IgM Detection as a Better Strategy to Prevent Second Infection Spreading Waves
2차 감염 확산을 방지하기 위한 더 나은 전략으로 결합된 anti-SARS-CoV-2 IgA, IgG 및 IgM 검출
Article
[키워드] absence
anti-SARS-CoV-2
anti-SARS-CoV-2 IgG
antibody
Antigen
antigens
atypical symptom
Better
Combined
complementary
Complete
Concentration
control group
coronavirus
coronavirus disease
COVID-19
COVID-19 patient
COVID-19 serological test
current
described
detection
Diagnosis
digestive
disease
ELISA
ELISA assay
enzyme
enzyme-linked immunosorbent
enzyme-linked immunosorbent assay
evaluated
false
false-negative
false-negative results
flowchart
focus
General population
gold
group
Health
IgA
IgG
IgM
IgM and IgG
Immune status
Immunity
immunoassay
Immunoglobulin
immunoglobulins
individual
Infection
International
involved
lateral flow immunoassay
lateral flow immunoassay (LFIA).
lead
LFIA
methodology
mucosal
occur
Outbreaks
outcomes
Patient
persistence
reported
respiratory
respiratory symptom
RT-PCR assay
RT-PCR assays
SARS-CoV-2
second
serological
serological test
Serological tests
spreading
Standardization
Strategy
Symptom
Variability
Wave
[DOI] 10.1080/08820139.2020.1823407 PMC 바로가기 [Article Type] Article
[DOI] 10.1080/08820139.2020.1823407 PMC 바로가기 [Article Type] Article